by Michael Schlander(Institute for Innovation & Valuation in Health Care (InnoVal HC) Wiesbaden, Germany, University of Heidelberg, Mannheim Medical Faculty (Institute for Public Health, Social and Preventive Medicine) Mannheim, Germany, University of Applied Economic Sciences LudwigshafenLudwigshafen am Rhein, Germany)
Current Pharmaceutical Design, 2010, 16, 2443-2461
This site complies with the HONcode standard for trustworthy health information: verify here.
Common Issue Texts Results of research The Pharmaceutical Economics of Child Psychiatric Drug Treatment
